Sign in
Not yet recruitingNo phase

A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia

Key facts

Who runs it
Zhonghao Fang
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
2,700 people, planned
Started
1 May 2026
Expected to end
28 May 2028
Type of study
Observational, 3 groups
Record updated
5 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criterionHide the full registry criteria

Other criteria

  • Inclusion and Exclusion Criteria for Pneumonia Patients 1.1 Inclusion Criteria 1) Age ≥ 18 years old; 2) Meeting the diagnostic criteria for pneumonia (acute onset + new infiltrates on imaging); 3) Time from onset to admission ≤ 72 hours; 4) Signed written informed consent. 1.1.1 Inclusion Criteria for Severe Pneumonia Patients A diagnosis of "severe pneumonia" can be made if one of the main criteria or ≥ 3 of the secondary criteria are met; Main Criteria:; ① Requires mechanical ventilation with tracheal intubation; ② Requires vasopressor drugs after aggressive fluid resuscitation for septic shock; Secondary Criteria:; Respiratory rate ≥ 30 breaths/min; PaO₂/FiO₂ ≤ 250 mm Hg; Multiple lobe infiltrates; Confusion and/or disorientation; ⑤ Blood urea nitrogen ≥ 20 mg/dL; ⑥ Leukopenia (WBC < 4×10⁹/L); ⑦ Thrombocytopenia (PLT < 100×10⁹/L); ⑧ Decreased body temperature (central body temperature < 36 ℃); ⑨ Hypotension requiring fluid resuscitation 1.2 Exclusion Criteria; End-stage diseases (such as expected survival < 48 hours); Long-term immunosuppressive therapy (prednisone > 20mg/d for more than 3 weeks, or neutropenia after chemotherapy); Pregnant or lactating women. 2. Inclusion and Exclusion Criteria for Patients with Suspected Infection but Negative Pathogen Testing 2.1 Inclusion Criteria; <!-- -->; Age ≥ 18 years old; Having infection-related symptoms or signs (such as fever, cough, sputum production, elevated white blood cells, etc.), clinically suspected of pneumonia; All pathogen tests are negative within 3 days after admission; Time from onset to admission ≤ 72 hours; Signed written informed consent. 2.2 Exclusion Criteria; <!-- -->; End-stage diseases (such as expected survival < 48 hours); Long-term immunosuppressive therapy; Pregnant or lactating women

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Pneumonia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, multicenter observational cohort study involving approximately 2,700 patients, designed to delineate the natural history of pneumonia by tracking the complete clinical course and dynamic multi-omics evolution from the acute phase to recovery; the study aims to quantify severe conversion rates and mortality by comparing baseline characteristics, pathogen distribution, and immune response trajectories between severe and non-severe groups, ultimately revealing the underlying molecular mechanisms of disease progression and optimizing clinical risk stratification strategies.

The 3 groups in the trial

  • pneumonia
  • Severe pneumonia
  • Non-infection control group

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07567911, who can take part
Record updated
5 May 2026